DAVITA INC. Proceeds from Lines of Credit
DAVITA INC. (DVA) reported Proceeds from Lines of Credit of $3.00 billion for the 12-month period ending 2012-12-31, per its 10-K filed 2014-02-21.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromLinesOfCredit · last filed 2014-02-21
- DAVITA INC. proceeds from lines of credit for fiscal 2012 was $3.00B.
- DAVITA INC. proceeds from lines of credit for fiscal 2010 was $2.75B.
| Period end | Proceeds from Lines of Credit 12 month |
|---|---|
| 2012-12-31 | $3.00B 10-K · filed 2014-02-21 |
| 2011-12-31 | $2.75B 8-K · filed 2012-07-06 |
| 2010-12-31 | $2.75B 10-K · filed 2011-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |